Inari Medical is a medical device company. Co.'s product offerings consist of two minimally-invasive, catheter-based mechanical thrombectomy systems for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, deep vein thrombosis, or DVT, and pulmonary embolism. Co.'s solutions include: ClotTriever System, which is a mechanical thrombectomy system designed to core, capture and remove clots from vessels and is used to treat DVT; FlowTriever System, which is a bore catheter-based aspiration and mechanical thrombectomy system; and ancillary products, which include FlowSaver, FlowStasis, and FlowTriever 2. The NARI average annual return since 2020 is shown above.
The Average Annual Return on the NARI average annual return since 2020 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether NARI average annual return since 2020 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the NARI average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|